The Board of Partners of E. Merck KG, Darmstadt, Germany, appointed Kai Beckmann as future Chair of the Executive Board and CEO. Darmstadt, Germany Belén Garijo’s successful tenure to be completed as planned by end of April 2026 Kai Beckmann appointed as Chair of the Executive Board and CEO effective May 1, 2026, ensuring a […]

Introduction Monoclonal antibodies (mAbs) remain one of the most widely used therapeutic modalities across oncology, autoimmune diseases, and infectious diseases. In upstream development, accurate and timely measurement of mAb concentration is essential for clone selection, process optimisation, and early screening workflows. Conventional techniques such as enzyme-linked immunosorbent assays (ELISA) and conventional high-performance liquid chromatography (HPLC) […]

Combination of Revvity’s proprietary Pin-point platform and Profluent’s AI-engineered proteins created to inspire accelerated development of novel gene editing therapies WALTHAM, Mass. —  Revvity, Inc. (NYSE: RVTY) announced a strategic collaboration with Profluent, bringing together a range of its novel AI-engineered enzymes with Revvity’s established Pin-pointTM base editing platform. The result is simplified access for customers to a therapeutically […]

Tempe, AZ — Biosensing Instrument Inc (BI) introduces today SPRm 220, a new cell-based surface plasmon resonance (SPR) system.  Building on the award-winning SPR microscopy technology first launched in 2017, the SPRm 220 brings enhanced throughput, improved usability, and unmatched capability in label-free, cell-based kinetic analysis. Designed specifically for the challenges of membrane protein research, […]

Stockholm, Sweden – Atlas Antibodies proudly announces the launch of AtlasPlex, a complete and customizable multiplex immunohistochemistry (mIHC-IF) solution for FFPE and fresh-frozen tissue. “AtlasPlex marks a significant milestone in Atlas Antibodies’ innovation journey with a strong dedication to preserving and advancing the legacy of the Human Protein Atlas. It’s a testament to what focused innovation and […]

Introduction Adeno-associated virus (AAV) vectors have become a cornerstone of gene therapy, valued for their safety, broad targeting capabilities, and adaptability across therapeutic applications. As development advances from research to process refinement, reliable quantification of total AAV capsid concentration is key to maintaining consistency and supporting informed decision-making. Traditional methods such as ELISA can be […]

Targeted proteomics panel delivers absolute quantification of key and emerging biomarkers in one scalable assay WALTHAM, Mass. — Thermo Fisher Scientific Inc., the world leader in serving science, today announced the launch of the Olink® Target 48 Neurodegeneration panel, a high-performance, targeted proteomics immunoassay panel developed to accelerate discoveries in neurodegenerative disease research. With diseases such […]

LOS ANGELES — Molecular Instruments® (MI), founded by the inventor of the HCR™ technology, today announces the upcoming release of the HCR™ HiFi Encoder, a breakthrough advance in multiplex immunofluorescence (IF) that enables users to robustly encode best-in-class quantitative signal amplification to their favorite primary antibodies. The HCR™ HiFi Encoder represents a game-changer across the […]

Männedorf, Switzerland – The Tecan Group (SIX Swiss Exchange: TECN) today announced a change of leadership in its Partnering Business division. Ralf Griebel, who has served as Head of the Partnering Business division and as a member of the Management Board since April 2020, will be leaving the Company to pursue other opportunities. The Board […]

Company to drive innovation and growth in key biotech market with office opening in Woodbury, NY BALTIMORE, MD — BioIVT, a global research partner and biospecimen solutions provider for drug and diagnostic development, today announced a company milestone with a new office space, including a state-of-the-art laboratory in Woodbury, New York. This expansion supports the […]